Literature DB >> 4925983

Antinuclear antibodies: their significance in scleroderma.

R E Jordon, D Deheer, A Schroeter, R K Winkelmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4925983

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  6 in total

1.  Lymphokine stimulation of collagen accumulation.

Authors:  R L Johnson; M Ziff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

2.  Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis: specificity and clinical correlations.

Authors:  A Aeschlimann; O Meyer; P Bourgeois; T Haim; N Belmatoug; E Palazzo; M F Kahn
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

3.  Immunohistological studies of the kidney in systemic lupus erythematosus and systemic sclerosis using antisera to IgG, C3, fibrin, and human renal glomeruli.

Authors:  D G Scott; N R Rowell
Journal:  Ann Rheum Dis       Date:  1974-09       Impact factor: 19.103

4.  Immunological studies in childhood scleroderma.

Authors:  W Stögmann; M Sandhofer; J Fritz
Journal:  Eur J Pediatr       Date:  1977-02-21       Impact factor: 3.183

5.  Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).

Authors:  H Kondo; B S Rabin; G P Rodnan
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

6.  Abnormal monocyte cytotoxicity and cyclic-AMP levels in systemic sclerosis.

Authors:  T Herlin; J Eggert; K Kragballe; H Zachariae
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.